Perritt Capital Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,500
| Closed | -$328K | – | 310 |
|
|
2022
Q3 | $328K | Hold |
30,500
| – | – | 0.21% | 113 |
|
|
2022
Q2 | $366K | Hold |
30,500
| – | – | 0.22% | 115 |
|
|
2022
Q1 | $653K | Sell |
30,500
-1,500
| -5% | -$32.1K | 0.35% | 80 |
|
|
2021
Q4 | $1.08M | Hold |
32,000
| – | – | 0.56% | 37 |
|
|
2021
Q3 | $824K | Hold |
32,000
| – | – | 0.45% | 58 |
|
|
2021
Q2 | $428K | Hold |
32,000
| – | – | 0.22% | 125 |
|
|
2021
Q1 | $340K | Hold |
32,000
| – | – | 0.19% | 140 |
|
|
2020
Q4 | $257K | Buy |
32,000
+2,500
| +8% | +$20.1K | 0.16% | 151 |
|
|
2020
Q3 | $221K | Hold |
29,500
| – | – | 0.16% | 141 |
|
|
2020
Q2 | $266K | Sell |
29,500
-8,000
| -21% | -$72.1K | 0.2% | 126 |
|
|
2020
Q1 | $359K | Buy |
37,500
+1,500
| +4% | +$14.4K | 0.29% | 107 |
|
|
2019
Q4 | $518K | Buy |
36,000
+2,500
| +7% | +$36K | 0.25% | 115 |
|
|
2019
Q3 | $504K | Buy |
+33,500
| New | +$504K | 0.21% | 130 |
|